jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Queen (Female) Full Body

Full Body

98 parameters

image

Report in 24Hrs

image

At Home

fastingrequire

Fasting Required

Details

Advanced Health covering Blood, Diabetes, Heart, Liver, Kidney, Thyroid, Iron, Sugar, Inflamation, Bone, Vitamins, Urine, Hormone, Cancer Marker

₹2,220₹3,999

44% OFF

Parameters

  • List of Tests
    • Sugar (Glucose) Random
    • CBC - Complete Hemogram
    • Liver Function Test
      • Albumin
      • Alkaline Phosphatase
      • Bilirubin - Direct
      • Bilirubin - Indirect
      • Bilirubin - Total
      • AST/SGOT
      • ALT/SGPT
      • Total Protein
      • A/G Ratio
      • Gamma GT
      • Globulin
    • Kidney Profile
      • BUN
      • Calcium
      • Creatinine
      • Uric Acid
      • eGFR
      • BUN/Creatinine
      • Urea
    • Lipid Profile
      • Cholestrol/HDL
      • LDL/HDL
      • Non HDL
      • VLDL
      • Total Cholestrol
      • Triglycerides
      • HDL
      • LDL
    • Iron Studies
      • Iron
      • TIBC
      • Transferrin Saturation
    • Thyroid Profile
      • Total T3
      • Total T4
      • TSH
    • Hba1c, eAG
    • ESR
    • Calcium
    • Vitamin B12
    • 25 OH Vitamin D
    • Urine Complete
    • Progesterone
    • CA125

Advanced Wellness Package - Queen

  • Why is it done?
    • Comprehensive health screening for women to assess overall wellness and detect early signs of disease
    • Glucose (Random): Screens for diabetes and prediabetes; identifies impaired glucose metabolism in women of all ages
    • CBC - Complete Hemogram (28): Evaluates blood cell counts and hemoglobin levels; detects anemia, infections, and blood disorders common in women
    • Liver Function Test (11): Assesses liver health and function; detects hepatitis, cirrhosis, and metabolic disorders
    • Kidney Profile (7): Evaluates renal function and electrolyte balance; screens for chronic kidney disease and stone formation
    • Lipid Profile (8): Measures cholesterol and triglycerides; assesses cardiovascular disease risk in women
    • Iron Studies (3): Evaluates iron metabolism; screens for anemia and iron overload conditions
    • Thyroid Profile (3): Assesses thyroid hormone levels; detects hypothyroidism and hyperthyroidism common in women
    • HbA1c and eAG: Monitors long-term glucose control; identifies diabetes and prediabetes over 2-3 months
    • ESR (Erythrocyte Sedimentation Rate): Screens for inflammation and infection; helps detect autoimmune and inflammatory conditions
    • Calcium: Assesses bone health and parathyroid function; important for postmenopausal women
    • Vitamin B12: Screens for vitamin deficiency; detects pernicious anemia and neurological complications
    • 25-OH Vitamin D: Evaluates vitamin D status; critical for bone health, immunity, and metabolic function
    • Urine Complete (18): Assesses kidney and urinary tract health; screens for infections, kidney disease, and diabetes
    • Progesterone: Evaluates ovarian function and reproductive health; important for women in reproductive years
    • CA125: Tumor marker screening; particularly relevant for ovarian cancer risk assessment in women
    • Package is ideal for annual wellness examinations, preventive health screening, and baseline health assessment
    • Recommended for women aged 30 and above for comprehensive health monitoring
  • Normal Range
    • Glucose (Random): 70-100 mg/dL (fasting); <140 mg/dL (random) - Normal glucose metabolism
    • CBC - Hemoglobin: 12.0-16.0 g/dL (females); RBC: 4.0-5.5 million/μL; WBC: 4,500-11,000/μL; Platelets: 150,000-400,000/μL
    • Liver Function: Albumin 3.5-5.0 g/dL; Alkaline Phosphatase 30-120 U/L; Total Bilirubin 0.3-1.2 mg/dL; AST 10-40 U/L; ALT 7-56 U/L; Total Protein 6.0-8.3 g/dL; A/G Ratio 1.0-2.5; Gamma GT 9-48 U/L
    • Kidney Profile: BUN 7-20 mg/dL; Calcium 8.5-10.2 mg/dL; Creatinine 0.6-1.2 mg/dL (female); Uric Acid 2.6-6.0 mg/dL (female); eGFR >60 mL/min/1.73m²; BUN/Creatinine ratio 10-20; Urea 7-20 mg/dL
    • Lipid Profile: Total Cholesterol <200 mg/dL; HDL >50 mg/dL (female); LDL <100 mg/dL; Triglycerides <150 mg/dL; VLDL <30 mg/dL; Non-HDL <130 mg/dL; Cholesterol/HDL ratio <5.0; LDL/HDL ratio <3.0
    • Iron Studies: Iron 50-150 μg/dL (female); TIBC 250-425 μg/dL; Transferrin Saturation 20-50%
    • Thyroid Profile: Total T3 80-200 ng/dL; Total T4 4.5-12.0 μg/dL; TSH 0.4-4.0 mIU/L
    • HbA1c: <5.7% (normal); 5.7-6.4% (prediabetes); >6.5% (diabetes); eAG equivalent glucose in mg/dL
    • ESR: 0-20 mm/hour (female) - varies with age
    • Calcium (Serum): 8.5-10.2 mg/dL or 2.12-2.55 mmol/L
    • Vitamin B12: 200-900 pg/mL or 148-700 pmol/L
    • 25-OH Vitamin D: >30 ng/mL (sufficient); 20-29 ng/mL (insufficient); <20 ng/mL (deficient); Optimal: 30-100 ng/mL
    • Urine Complete: Negative for protein, glucose, blood, leukocytes, nitrites; pH 4.5-8.0; Specific gravity 1.005-1.030; No casts or crystals in normal results
    • Progesterone (Luteal Phase): 5-20 ng/mL (follicular phase); >10 ng/mL (luteal phase) - indicates ovulation
    • CA125: <35 U/mL (normal, non-pregnant women)
  • Interpretation
    • Glucose (Random): 100-125 mg/dL indicates prediabetes; >126 mg/dL on repeat testing indicates diabetes; elevated levels suggest impaired glucose tolerance or insufficient insulin production
    • CBC Hemoglobin <12 g/dL indicates anemia; >16 g/dL indicates polycythemia; Low RBC with normal hemoglobin suggests macrocytic anemia; High WBC suggests infection or leukemia; Low platelets increase bleeding risk
    • Liver Function - High AST/ALT: indicates hepatocellular injury; AST>ALT in alcoholic liver disease; High Bilirubin: suggests jaundice or hemolysis; Low Albumin: indicates chronic liver disease or malnutrition; High Alkaline Phosphatase: suggests cholestasis or bone disease; High Gamma GT: correlates with AST/ALT elevation
    • Kidney Profile - High Creatinine/BUN: suggests declining renal function; eGFR <60 indicates chronic kidney disease; High Uric Acid: risk of gout; Low Calcium: may indicate vitamin D deficiency or chronic kidney disease; High BUN/Creatinine ratio: suggests dehydration or prerenal azotemia
    • Lipid Profile - High LDL/Total Cholesterol: increases cardiovascular disease risk; Low HDL: independent risk factor for heart disease; High Triglycerides: associated with metabolic syndrome; Non-HDL elevation: indicates atherogenic dyslipidemia
    • Iron Studies - Low Iron with High TIBC: indicates iron deficiency anemia; Low Transferrin Saturation: confirms iron deficiency; High Iron with High Ferritin: suggests hemochromatosis or iron overload; Normal Saturation 20-50% indicates adequate iron stores
    • Thyroid Profile - Low TSH with High T4/T3: indicates hyperthyroidism (Graves disease, thyroiditis); High TSH with Low T4: indicates hypothyroidism (Hashimoto's); Isolated TSH elevation: subclinical hypothyroidism; Normal values exclude thyroid dysfunction
    • HbA1c 5.7-6.4%: prediabetic range requiring lifestyle modifications; >6.5%: diagnostic of diabetes; Trends over time show glucose control quality; eAG provides average glucose in mg/dL for easier patient understanding
    • ESR Elevated: suggests inflammation, infection, malignancy, or autoimmune disease; Degree of elevation correlates with severity; ESR normal but symptoms present: consider other inflammatory markers; Age-adjusted values important in interpretation
    • Calcium - Hypercalcemia (>10.2): may indicate hyperparathyroidism, malignancy, vitamin D toxicity; Hypocalcemia (<8.5): suggests hypoparathyroidism, vitamin D deficiency, kidney disease; Ionized calcium preferred for critically ill patients
    • Vitamin B12 - 200-300 pg/mL: borderline low, consider supplementation; <200 pg/mL: deficiency confirmed; elevated: typically not harmful but may indicate kidney disease; Symptoms of deficiency include neuropathy and anemia
    • Vitamin D - <20 ng/mL: severe deficiency requiring aggressive supplementation; 20-29 ng/mL: insufficient, increase sun exposure and supplementation; 30-100 ng/mL: optimal range for bone and immune health; >100 ng/mL: potential toxicity risk
    • Urine Complete - Proteinuria: indicates kidney disease; Hematuria: suggests urinary tract infection, stones, or glomerulonephritis; Glycosuria: indicates poorly controlled diabetes; Leukocyte esterase: suggests UTI; Nitrites: bacterial infection present
    • Progesterone - <1 ng/mL during follicular phase; >10 ng/mL during luteal phase confirms ovulation; Low levels in luteal phase suggest anovulation or luteal phase defect; Timing of collection critical for interpretation
    • CA125 - Elevated levels (>35 U/mL): may indicate ovarian cancer, but also elevated in benign conditions like endometriosis, menstruation, and other cancers; Serial measurement more useful than single value; Often used with imaging for ovarian cancer screening
  • Associated Organs
    • Glucose (Random): Pancreas (insulin production), liver (glucose metabolism); Abnormalities lead to diabetes, hypoglycemia, and metabolic complications
    • CBC: Bone marrow (production site), spleen (storage), blood; Abnormalities indicate anemia, leukemia, infections, immune disorders
    • Liver Function Tests: Liver (primary organ); Abnormalities indicate hepatitis, cirrhosis, fatty liver, autoimmune liver disease, malignancy
    • Kidney Profile: Kidneys (filtration and regulation); Abnormalities indicate glomerulonephritis, chronic kidney disease, acute kidney injury, kidney stones
    • Lipid Profile: Heart and blood vessels (primary concern), liver (cholesterol synthesis); Abnormalities increase risk of atherosclerosis, myocardial infarction, stroke
    • Iron Studies: Bone marrow (RBC production), intestines (absorption), liver and spleen (storage); Abnormalities cause anemia or hemochromatosis with organ damage
    • Thyroid Profile: Thyroid gland (hormone production); Abnormalities cause hypothyroidism, hyperthyroidism, affecting metabolism and multiple organ systems
    • HbA1c and eAG: Pancreas and blood glucose metabolism; Reflects damage to kidneys, eyes, nerves, heart in diabetes
    • ESR: Reflects inflammation in any organ system; helps detect infection, autoimmune disease, malignancy, tissue inflammation
    • Calcium: Bones (storage), parathyroid gland (regulation), kidneys (reabsorption), intestines (absorption); Critical for bone health and muscle function
    • Vitamin B12: Stomach and intestines (absorption), bone marrow (RBC production), nervous system (myelin synthesis); Deficiency causes pernicious anemia and neuropathy
    • Vitamin D: Intestines (absorption), bones (mineralization), immune system, kidneys (metabolism); Deficiency causes osteoporosis, rickets, immune dysfunction
    • Urine Complete: Kidneys and urinary tract (collection and filtration); Abnormalities indicate kidney disease, UTI, diabetes complications, proteinuria
    • Progesterone: Ovaries (production), uterus (endometrium receptivity); Abnormalities indicate ovulatory disorders, infertility, luteal phase defect
    • CA125: Ovaries (primary concern for malignancy), peritoneum, pancreas; Elevated in ovarian cancer and other adenocarcinomas; also raised in benign gynecological conditions
  • Follow-up Tests
    • Glucose Abnormalities: Fasting glucose, OGTT (Oral Glucose Tolerance Test), HbA1c; insulin level, C-peptide for further characterization
    • CBC Abnormalities: Peripheral blood smear, reticulocyte count, bone marrow biopsy if indicated; specific iron studies for anemia; platelet dysfunction tests if thrombocytopenia
    • Liver Function Abnormalities: Viral hepatitis serology (A, B, C), autoimmune markers (ANA, anti-mitochondrial), ultrasound abdomen, liver biopsy if clinically indicated
    • Kidney Function Abnormalities: Urine protein-to-creatinine ratio, renal ultrasound, CT imaging, renal biopsy if glomerulonephritis suspected; monitor eGFR quarterly
    • Lipid Profile Abnormalities: Lipoprotein(a), apolipoproteins, cardiac risk assessment, ECG, stress test; repeat lipid profile after intervention (3 months)
    • Iron Studies Abnormalities: Serum ferritin, iron saturation trends; genetic testing for hemochromatosis; bone marrow evaluation if sideroblastic anemia suspected
    • Thyroid Abnormalities: Free T4, Free T3, TPO antibodies, thyroglobulin antibodies; ultrasound thyroid if nodule suspected; repeat TSH every 6-8 weeks after treatment adjustment
    • HbA1c Abnormalities: Continuous glucose monitoring, fasting and postprandial glucose testing, C-peptide levels; endocrinology referral if poorly controlled
    • Elevated ESR: CRP (C-reactive protein), specific testing based on suspected diagnosis (rheumatoid factor, ANA); imaging studies for malignancy if indicated
    • Calcium Abnormalities: Parathyroid hormone (PTH), phosphate, magnesium, vitamin D metabolites; imaging of parathyroids if hyperparathyroidism suspected
    • Vitamin B12 Deficiency: Methylmalonic acid, homocysteine, intrinsic factor antibodies, parietal cell antibodies; B12 supplementation trial; GI evaluation if malabsorption suspected
    • Vitamin D Deficiency: Parathyroid hormone, calcium, phosphate, alkaline phosphatase; DEXA scan for bone density; repeat 25-OH Vitamin D after 8-12 weeks supplementation
    • Urine Abnormalities: Urine culture if infection suspected, urine protein-to-creatinine ratio for proteinuria, ultrasound or CT imaging for stones or structural abnormalities
    • Progesterone Abnormalities: FSH, LH, estradiol, prolactin levels; pelvic ultrasound to assess ovaries; further endocrinology evaluation if PCOS or other disorders suspected
    • CA125 Elevation: Transvaginal ultrasound, pelvic imaging, gynecologic oncology consultation; repeat CA125 testing in 4-6 weeks; consider other tumor markers (CEA, HE4) for better specificity
    • Annual testing recommended for monitoring chronic conditions; quarterly assessments if abnormalities detected; specialist referral based on specific abnormal results
  • Fasting Required?
    • YES - Fasting of 10-12 hours is required for this test package for accurate results
    • Fasting Duration: Minimum 10-12 hours overnight fast; preferably start fast after 8 PM and collect blood in the morning
    • Dietary Restrictions: No food consumption during fasting period; lipid profile accuracy specifically requires fasting due to postprandial lipemia effect
    • Fluid Intake: Water intake is allowed and encouraged during fasting; avoid sugared drinks, coffee, tea, juices, and alcohol
    • Medications: Take regular medications with water unless specifically instructed otherwise by your physician; inform laboratory of any medications taken
    • Special Considerations for Women: Progesterone test timing should be mid-luteal phase (21 days after first day of menstrual cycle); collect blood 7 days before expected menstruation
    • Stress Reduction: Avoid strenuous physical activity 24 hours before testing; avoid smoking at least 30 minutes before blood collection
    • Collection Time: Schedule testing in early morning (7-9 AM) when fasting compliance is best; blood must be collected after fasting period
    • Urine Sample: First morning urine is preferred for urine complete test; void completely into clean container
    • Menstrual Cycle Effects: If possible, avoid testing during menstruation as this may affect hemoglobin and some urine parameters; CA125 levels may also be elevated during menstruation
    • Post-Collection: Eat and drink normally after blood collection; results typically available within 24-48 hours

How our test process works!

customers
customers